Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

Share Price is delayed by 15 minutes
Get Live Data
217.00    -2.00 (-0.91%)
Bid:
217.00
Ask:
217.50
Spread: 0.50 (0.23%)
Market Cap: £599.82m
MGAM Live PriceLast checked at - London Stock Exchange

Intraday Morgan Advanced Materials Share Chart

Q1 Trading Update

23 Apr 2018 07:00

RNS Number : 7079L
Morgan Advanced Materials PLC
23 April 2018
 

 

 

Press Release

 

Morgan Advanced Materials plc

23 April 2018

Q1 trading update

 

Sales for the first three months to March 2018 were 6.5% higher for the Group, on an organic constant currency basis, compared to the first quarter of last year.

 

By business, the organic constant currency trends for the first quarter compared to prior year are as follows. Sales for the Thermal Products division were 6.2% higher than the prior year, with growth in Asia and Europe. Within the Carbon and Technical Ceramics division, sales were 9.0% higher than last year, with above trend growth in Seals & Bearings driven by ceramic armour sales, good growth in Electrical Carbon, and modest growth in Technical Ceramics. The Composites and Defence Systems business has continued its recent declining trend.

 

Morgan Advanced Materials plc also announces that the Board has decided to exit the Composite and Defence Systems business. This exit will take the form of the potential divestment of certain product lines, should a suitable acquirer be found, together with the closure of the remainder of the business lines. Discussions with potential acquirers of certain product lines are at a very early stage, and there can be no certainty that any divestments will be made.

 

The provisional cash exit costs from closing the Composites and Defence Systems business are anticipated to be around £6 million, which may be partially offset by any proceeds from the divestment of certain product lines and the sale of certain fixed assets of the business.

 

Looking forward to the balance of the year for the Group as a whole, the growth rate achieved in the first quarter is higher than we anticipate for the full year, reflecting a relatively weaker comparator period in the first quarter of the prior year. We currently anticipate that full year headline operating profit margins will be slightly ahead of the prior year, with the benefits of pricing, efficiency savings and volume leverage being partially offset by the planned reinvestment in research and development and sales resources, as well as the dilutive impact of the divestments completed in 2017.

 

This announcement contains inside information, the person responsible for releasing this announcement on behalf of the company is Peter Turner.

For further enquiries:

 

Pete Raby

Morgan Advanced Materials plc

01753 837 000

Peter Turner

 

Alison Kay

 

Brunswick

 

0207 404 5959

 

Notes:

The next scheduled update is the Group's half-year results presentation on 26 July 2018.

Legal Entity Identifier: I4K14LL95N2PHDL7EG85

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTZXLBLVZFXBBD
Date   Source Headline
19th Sep 201610:52 amRNSDirector/PDMR Shareholding
13th Sep 201611:43 amRNSDirector/PDMR Shareholding
23rd Aug 20163:59 pmRNSHolding(s) in Company
28th Jul 201611:40 amRNSHolding(s) in Company
27th Jul 20167:00 amRNSHalf-Year Results
29th Jun 20161:19 pmRNSHolding(s) in Company
29th Jun 20161:16 pmRNSHolding(s) in Company - Amendment
22nd Jun 201611:59 amRNSHolding(s) in Company
20th Jun 201611:22 amRNS2015 Environmental, Health and Safety Report
15th Jun 201610:18 amRNSBlock listing Interim Review
31st May 20162:55 pmRNSDirector/PDMR Shareholding
24th May 201612:31 pmRNSDirector/PDMR Shareholding
6th May 20162:23 pmRNSResult of AGM
6th May 20167:00 amRNSTrading update
18th Apr 20162:39 pmRNSDirector/PDMR Shareholding
8th Apr 20167:00 amRNSAppointment of Non-Executive Director
7th Apr 20164:30 pmRNSDirector/PDMR Shareholding
6th Apr 20161:18 pmRNSAnnual Financial Report
5th Apr 20167:00 amRNSDirectorate Change
30th Mar 20167:00 amRNSAppointment of Chief Financial Officer
24th Mar 20167:00 amRNSBoard Change
24th Feb 20161:08 pmRNSDirector/PDMR Shareholding
23rd Feb 20167:00 amRNSFinal Results
4th Feb 201610:56 amRNSDirectorate Change
1st Feb 20161:56 pmRNSDirector Declaration
22nd Jan 20167:00 amRNSAppointment of a Non-Executive Director
14th Jan 201612:33 pmRNSHolding(s) in Company
30th Dec 201510:10 amRNSDirector/PDMR Shareholding
18th Dec 20152:22 pmRNSDirector/PDMR Shareholding
16th Dec 20151:26 pmRNSAdoption of FRS 101 - Reduced Disclosure Framework
15th Dec 20153:56 pmRNSHolding(s) in Company
15th Dec 20153:16 pmRNSBlocklisting Interim Review
2nd Dec 20159:10 amRNSHolding(s) in Company
26th Nov 201512:22 pmRNSDirector/PDMR Shareholding
24th Nov 20153:25 pmRNSHolding(s) in Company
13th Nov 201512:18 pmRNSDirector/PDMR Shareholding
12th Nov 20157:00 amRNSTrading Update
9th Oct 201511:14 amRNSHolding(s) in Company
2nd Oct 20157:00 amRNSBoard Change
29th Sep 20152:47 pmRNSDirector/PDMR Shareholding
25th Sep 201510:43 amRNSDirector Declaration
17th Sep 201511:50 amRNSHolding(s) in Company
11th Sep 201511:23 amRNSHolding(s) in Company
10th Sep 20153:21 pmRNSHolding(s) in Company
2nd Sep 20159:11 amRNSDirector/PDMR Shareholding
20th Aug 201512:07 pmRNSDirector/PDMR Shareholding
4th Aug 201510:13 amRNSDirector/PDMR Shareholding
22nd Jul 20157:00 amRNSHalf Yearly Results
2nd Jul 20155:22 pmRNSHolding(s) in Company
15th Jun 20153:53 pmRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.